Current approaches to primary therapy for papillary and follicular thyroid cancer

被引：1003
作者：
Mazzaferri, EL
Kloos, RT
机构：
[1] Ohio State Univ, Ctr Hlth Outcome Policy & Evaluat Studies, Columbus, OH 43210 USA
[2] Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA
[3] Ohio State Univ, Div Nucl Med, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2001年 / 86卷 / 04期
关键词：
D O I：
10.1210/jc.86.4.1447
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1447 / 1463
页数：17
相关论文
共 147 条
[1]  
Akslen LA, 2000, CANCER, V88, P1902, DOI 10.1002/(SICI)1097-0142(20000415)88:8<1902::AID-CNCR20>3.0.CO
[2]  
2-Y
[3]  
Alexander C, 1998, J NUCL MED, V39, P1551
[4]  
*AM JOINT COMM CAN, 1992, MAN STAG CANC, P53
[5]  
[Anonymous], ENDOCRINE TUMORS
[6]  
Bal C, 1996, CANCER, V77, P2574, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2574::AID-CNCR22>3.3.CO
[7]  
2-S
[8]   THE MANAGEMENT OF DIFFERENTIATED THYROID-CANCER IN EUROPE IN 1988 - RESULTS OF AN INTERNATIONAL SURVEY [J].
BALDET, L ;
MANDERSCHEID, JC ;
GLINOER, D ;
JAFFIOL, C ;
COSTESEIGNOVERT, B ;
PERCHERON, C .
ACTA ENDOCRINOLOGICA, 1989, 120 (05) :547-558
[9]  
Baudin E, 1998, CANCER, V83, P553, DOI 10.1002/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO
[10]  
2-U
12345678910